Investing Ideas
/
Swedish Pharmaceuticals & Biotech Price disconnect

Swedish Pharmaceuticals & Biotech Price disconnect

Results

0 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

4 companies

Bonesupport Holding

Market Cap: SEK 15.1b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

BONEX

SEK 222.60

3.6%

-31.1%

Swedencare

Market Cap: SEK 3.5b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

SECARE

SEK 21.90

0.2%

-40.9%

Cantargia

Market Cap: SEK 439.5m

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

CANTA

SEK 1.80

-3.7%

-42.9%

Sprint Bioscience

Market Cap: SEK 382.0m

A pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.

SPRINT

SEK 3.60

-3.2%

500.0%